Cargando…

Clinical advancement of precision theranostics in prostate cancer

Theranostic approaches with positron emission tomography/computed tomography (PET/CT) or PET/magnetic resonance imaging (PET/MRI) molecular imaging probes are being implemented clinically in prostate cancer (PCa) diagnosis and imaging-guided precision surgery. This review article provides a comprehe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Yue, Fang, Zhihui, Tang, Yongxiang, Liu, Kai, Zhao, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932923/ https://www.ncbi.nlm.nih.gov/pubmed/36816956 http://dx.doi.org/10.3389/fonc.2023.1072510

Ejemplares similares

Prostate Cancer Theranostics - An Overview
por: Abou, Diane, et al.
Publicado: (2020)

Editorial: Radiomics-based theranostics in cancer precision medicine
por: Ji, Jiansong, et al.
Publicado: (2023)

Theranostic Pretargeting Drug Delivery and Imaging Platforms in Cancer Precision Medicine
por: Hapuarachchige, Sudath, et al.
Publicado: (2020)

Advances in Extracellular Vesicle Nanotechnology for Precision Theranostics
por: Wu, Qian, et al.
Publicado: (2022)

Advanced nanomaterial for prostate cancer theranostics
por: Hao, Bin, et al.
Publicado: (2022)

Insights into the theranostic value of precision medicine on advanced radiotherapy to breast cancer
por: Jiang, Man, et al.
Publicado: (2021)

Incorporating PSMA-Targeting Theranostics Into Personalized Prostate Cancer Treatment: a Multidisciplinary Perspective
por: Ng, Thomas S. C., et al.
Publicado: (2021)

Ovarian Cancer Targeted Theranostics
por: Nimmagadda, Sridhar, et al.
Publicado: (2020)

Nanozymes in Tumor Theranostics
por: Ma, Qiulian, et al.
Publicado: (2021)

Combined biology-guided radiotherapy and Lutetium PSMA theranostics treatment in metastatic castrate-resistant prostate cancer
por: Gaudreault, Mathieu, et al.
Publicado: (2023)

Path to Clonal Theranostics in Luminal Breast Cancers
por: Hajjaji, Nawale, et al.
Publicado: (2022)

Advancing theranostics with tumor-targeting peptides for precision otolaryngology
por: Wright, Chadwick L., et al.
Publicado: (2016)

Impact of Phosphoproteomics in the Era of Precision Medicine for Prostate Cancer
por: Ramroop, Johnny R., et al.
Publicado: (2018)

A New Era of Prostate Cancer Precision Medicine
por: Malik, Adil, et al.
Publicado: (2019)

Theranostic (64)Cu-DOTHA(2)-PSMA allows low toxicity radioligand therapy in mice prostate cancer model
por: Milot, Marie-Christine, et al.
Publicado: (2023)

Fibroblast activation protein-based theranostics in pancreatic cancer
por: Cheng, Chien-shan, et al.
Publicado: (2022)

GRPR versus PSMA: expression profiles during prostate cancer progression demonstrate the added value of GRPR-targeting theranostic approaches
por: Verhoeven, Marjolein, et al.
Publicado: (2023)

Theranostic digital twins for personalized radiopharmaceutical therapies: Reimagining theranostics via computational nuclear oncology
por: Rahmim, Arman, et al.
Publicado: (2022)

Exploring Small Extracellular Vesicles for Precision Medicine in Prostate Cancer
por: Giulietti, Matteo, et al.
Publicado: (2018)

A Review of 177Lutetium-PSMA and 225Actinium-PSMA as Emerging Theranostic Agents in Prostate Cancer
por: Alam, Mohammad R, et al.
Publicado: (2022)

Biomimetic Nanoparticles Camouflaged in Cancer Cell Membranes and Their Applications in Cancer Theranostics
por: Jin, Jiefu, et al.
Publicado: (2020)

Progression in immunotherapy for advanced prostate cancer
por: Liang, Hao, et al.
Publicado: (2023)

A new tumorgraft panel to accelerate precision medicine in prostate cancer
por: Béraud, Claire, et al.
Publicado: (2023)

Editorial: Radiomics Advances Precision Medicine
por: Gao, Bo, et al.
Publicado: (2022)

Recent Advances of Manganese-Based Hybrid Nanomaterials for Cancer Precision Medicine
por: Liu, Xiaoman, et al.
Publicado: (2021)

The Current Status and Future Potential of Theranostics to Diagnose and Treat Childhood Cancer
por: Poot, Alex J., et al.
Publicado: (2020)

MicroRNAs Role in Breast Cancer: Theranostic Application in Saudi Arabia
por: Alyami, Nouf M.
Publicado: (2021)

Diagnostic Performance of Theranostic Radionuclides Used in Transarterial Radioembolization for Liver Cancer
por: Li, Rou, et al.
Publicado: (2021)

Molecular classifications of prostate cancer: basis for individualized risk stratification and precision therapy
por: Ge, Qintao, et al.
Publicado: (2023)

Quantitative Mass Spectrometry-Based Proteomic Profiling for Precision Medicine in Prostate Cancer
por: Flores-Morales, Amilcar, et al.
Publicado: (2017)

Biomimetic nanomedicines for precise atherosclerosis theranostics
por: Tao, Ying, et al.
Publicado: (2023)

Editorial: Advances in radiotherapy for prostate cancer
por: Kamran, Sophia C., et al.
Publicado: (2022)

Precision strikes: PSMA-targeted radionuclide therapy in prostate cancer – a narrative review
por: Szponar, Paweł, et al.
Publicado: (2023)

Advancements in the treatment of metastatic hormone-sensitive prostate cancer
por: Li, Hengping, et al.
Publicado: (2022)

Current status of theranostics in prostate cancer
por: Virgolini, Irene, et al.
Publicado: (2017)

Prediction of clinically significant prostate cancer with a multimodal MRI-based radiomics nomogram
por: Jing, Guodong, et al.
Publicado: (2022)

Editorial: Tumor microenvironment targeted nanomedicine: a feasible strategy for cancer imaging and theranostics
por: Xu, Yiming, et al.
Publicado: (2023)

Precision Medicine in Lung Cancer Theranostics: Paving the Way from Traditional Technology to Advance Era
por: Guan, Xiaoyong, et al.
Publicado: (2022)

Infertility in Men: Advances towards a Comprehensive and Integrative Strategy for Precision Theranostics
por: Assidi, Mourad
Publicado: (2022)

Emerging nanobiotechnology for precise theranostics of hepatocellular carcinoma
por: Xu, Mengjiao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sg1n075kchu2chfdjqqbivv1fu